Peer review reports
From: Nobiletin suppresses cell viability through AKT Pathways in PC-3 and DU-145 prostate cancer cells
Original Submission | ||
---|---|---|
6 Jun 2014 | Submitted | Original manuscript |
Resubmission - Version 2 | ||
Submitted | Manuscript version 2 | |
10 Jun 2014 | Author responded | Author comments - Yi Chen |
Resubmission - Version 3 | ||
10 Jun 2014 | Submitted | Manuscript version 3 |
22 Sep 2014 | Reviewed | Reviewer Report - Liming Zhou |
6 Oct 2014 | Author responded | Author comments - Yi Chen |
Resubmission - Version 4 | ||
6 Oct 2014 | Submitted | Manuscript version 4 |
10 Oct 2014 | Author responded | Author comments - Yi Chen |
Resubmission - Version 5 | ||
10 Oct 2014 | Submitted | Manuscript version 5 |
Publishing | ||
14 Oct 2014 | Editorially accepted | |
24 Oct 2014 | Article published | 10.1186/2050-6511-15-59 |